Inovio Pharmaceuticals Inc
NASDAQ:INO

Watchlist Manager
Inovio Pharmaceuticals Inc Logo
Inovio Pharmaceuticals Inc
NASDAQ:INO
Watchlist
Price: 4.16 USD 2.46% Market Closed
Market Cap: 108m USD
Have any thoughts about
Inovio Pharmaceuticals Inc?
Write Note

Intrinsic Value

INO's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one INO stock under the Base Case scenario is 5.99 USD. Compared to the current market price of 4.16 USD, Inovio Pharmaceuticals Inc is Undervalued by 31%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

INO Intrinsic Value
5.99 USD
Undervaluation 31%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Inovio Pharmaceuticals Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for INO cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about INO?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Inovio Pharmaceuticals Inc

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Inovio Pharmaceuticals Inc

Provide an overview of the primary business activities
of Inovio Pharmaceuticals Inc.

What unique competitive advantages
does Inovio Pharmaceuticals Inc hold over its rivals?

What risks and challenges
does Inovio Pharmaceuticals Inc face in the near future?

Has there been any significant insider trading activity
in Inovio Pharmaceuticals Inc recently?

Summarize the latest earnings call
of Inovio Pharmaceuticals Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Inovio Pharmaceuticals Inc.

Provide P/S
for Inovio Pharmaceuticals Inc.

Provide P/E
for Inovio Pharmaceuticals Inc.

Provide P/OCF
for Inovio Pharmaceuticals Inc.

Provide P/FCFE
for Inovio Pharmaceuticals Inc.

Provide P/B
for Inovio Pharmaceuticals Inc.

Provide EV/S
for Inovio Pharmaceuticals Inc.

Provide EV/GP
for Inovio Pharmaceuticals Inc.

Provide EV/EBITDA
for Inovio Pharmaceuticals Inc.

Provide EV/EBIT
for Inovio Pharmaceuticals Inc.

Provide EV/OCF
for Inovio Pharmaceuticals Inc.

Provide EV/FCFF
for Inovio Pharmaceuticals Inc.

Provide EV/IC
for Inovio Pharmaceuticals Inc.

Show me price targets
for Inovio Pharmaceuticals Inc made by professional analysts.

What are the Revenue projections
for Inovio Pharmaceuticals Inc?

How accurate were the past Revenue estimates
for Inovio Pharmaceuticals Inc?

What are the Net Income projections
for Inovio Pharmaceuticals Inc?

How accurate were the past Net Income estimates
for Inovio Pharmaceuticals Inc?

What are the EPS projections
for Inovio Pharmaceuticals Inc?

How accurate were the past EPS estimates
for Inovio Pharmaceuticals Inc?

What are the EBIT projections
for Inovio Pharmaceuticals Inc?

How accurate were the past EBIT estimates
for Inovio Pharmaceuticals Inc?

Compare the revenue forecasts
for Inovio Pharmaceuticals Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Inovio Pharmaceuticals Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Inovio Pharmaceuticals Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Inovio Pharmaceuticals Inc compared to its peers.

Compare the P/E ratios
of Inovio Pharmaceuticals Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Inovio Pharmaceuticals Inc with its peers.

Analyze the financial leverage
of Inovio Pharmaceuticals Inc compared to its main competitors.

Show all profitability ratios
for Inovio Pharmaceuticals Inc.

Provide ROE
for Inovio Pharmaceuticals Inc.

Provide ROA
for Inovio Pharmaceuticals Inc.

Provide ROIC
for Inovio Pharmaceuticals Inc.

Provide ROCE
for Inovio Pharmaceuticals Inc.

Provide Gross Margin
for Inovio Pharmaceuticals Inc.

Provide Operating Margin
for Inovio Pharmaceuticals Inc.

Provide Net Margin
for Inovio Pharmaceuticals Inc.

Provide FCF Margin
for Inovio Pharmaceuticals Inc.

Show all solvency ratios
for Inovio Pharmaceuticals Inc.

Provide D/E Ratio
for Inovio Pharmaceuticals Inc.

Provide D/A Ratio
for Inovio Pharmaceuticals Inc.

Provide Interest Coverage Ratio
for Inovio Pharmaceuticals Inc.

Provide Altman Z-Score Ratio
for Inovio Pharmaceuticals Inc.

Provide Quick Ratio
for Inovio Pharmaceuticals Inc.

Provide Current Ratio
for Inovio Pharmaceuticals Inc.

Provide Cash Ratio
for Inovio Pharmaceuticals Inc.

What is the historical Revenue growth
over the last 5 years for Inovio Pharmaceuticals Inc?

What is the historical Net Income growth
over the last 5 years for Inovio Pharmaceuticals Inc?

What is the current Free Cash Flow
of Inovio Pharmaceuticals Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Inovio Pharmaceuticals Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Inovio Pharmaceuticals Inc

Current Assets 91.3m
Cash & Short-Term Investments 84.8m
Receivables 1.9m
Other Current Assets 4.6m
Non-Current Assets 15.8m
Long-Term Investments 2.6m
PP&E 12.6m
Other Non-Current Assets 566.4k
Current Liabilities 23.5m
Accounts Payable 5.4m
Accrued Liabilities 18.1m
Non-Current Liabilities 10m
Other Non-Current Liabilities 10m
Efficiency

Earnings Waterfall
Inovio Pharmaceuticals Inc

Revenue
203.8k USD
Operating Expenses
-119.6m USD
Operating Income
-119.4m USD
Other Expenses
6.5m USD
Net Income
-112.9m USD

Free Cash Flow Analysis
Inovio Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

INO Profitability Score
Profitability Due Diligence

Inovio Pharmaceuticals Inc's profitability score is 12/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Negative 1-Year Revenue Growth
Declining ROE
Declining ROIC
12/100
Profitability
Score

Inovio Pharmaceuticals Inc's profitability score is 12/100. The higher the profitability score, the more profitable the company is.

INO Solvency Score
Solvency Due Diligence

Inovio Pharmaceuticals Inc's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
47/100
Solvency
Score

Inovio Pharmaceuticals Inc's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

INO Price Targets Summary
Inovio Pharmaceuticals Inc

Wall Street analysts forecast INO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for INO is 10.88 USD with a low forecast of 5.05 USD and a high forecast of 18.9 USD.

Lowest
Price Target
5.05 USD
21% Upside
Average
Price Target
10.88 USD
162% Upside
Highest
Price Target
18.9 USD
354% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for INO?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for INO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

INO Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

INO News

Other Videos

Profile

Inovio Pharmaceuticals Inc Logo
Inovio Pharmaceuticals Inc

Country

United States of America

Industry

Biotechnology

Market Cap

108.4m USD

Dividend Yield

0%

Description

Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. The company is headquartered in San Diego, California and currently employs 317 full-time employees. The firm is focused on bringing to market designed deoxyribonucleic acid (DNA) medicines and vaccines to help protect people from infectious diseases, including COVID-19, and to help treat people with cancer, and conditions associated with human papillomavirus (HPV). Its DNA medicines pipeline consists of three types of product candidates, namely prophylactic DNA vaccines, therapeutic DNA immunotherapies, and DNA encoded monoclonal and bispecific antibodies (dMAbs and dBTAs), which utilizes the two components of INOVIO's integrated platform, SynCon and CELLECTRA. The firm's SynCon technology creates optimized plasmids. INOVIO's CELLECTRA smart delivery devices facilitate uptake of its DNA medicines into the cell. Its SynCon DNA medicines are designed to generate antigen-specific antibody and T cell responses.

Contact

CALIFORNIA
San Diego
6769 Mesa Ridge Rd
+18584103134.0
www.inovio.com

IPO

1998-12-08

Employees

317

Officers

CEO, President & Director
Dr. Jacqueline E. Shea Ph.D.
Chief Financial Officer
Mr. Peter D. Kies
Chief Scientific Officer & Chairman of the Scientific Advisory Board
Dr. Laurent M. Humeau Ph.D.
Manager of Investor Relations
Thomas Hong
General Counsel & Chief Compliance Officer
Mr. Robert L. Crotty J.D.
Senior Vice President of Quality Assurance
Mr. E. J. Brandreth MBA
Show More
Senior Vice President of Clinical Development
Dr. Jeffrey Skolnik
Senior Vice President of Biological Manufacturing & Clinical Supply Management
Mr. Robert J. Juba Jr.
Show Less

See Also

Discover More
What is the Intrinsic Value of one INO stock?

The intrinsic value of one INO stock under the Base Case scenario is 5.99 USD.

Is INO stock undervalued or overvalued?

Compared to the current market price of 4.16 USD, Inovio Pharmaceuticals Inc is Undervalued by 31%.

Back to Top